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[FeFe]-Hydrogenases: recent developments and
future perspectives
F. Wittkamp,a M. Senger,b S. T. Stripp b and U.-P. Apfel *ac
[FeFe]-Hydrogenases are the most eﬃcient enzymes for catalytic hydrogen turnover. Their H2 production
eﬃciency is hitherto unrivalled. However, functional details of the catalytic machinery and possible modes
of application are discussed controversially. The incorporation of synthetically modified cofactors and
utilization of semi-artificial enzymes only recently allowed us to shed light on key steps of the catalytic
cycle. Herein, we summarize the essential findings regarding the redox chemistry of [FeFe]-hydrogenases
and discuss their catalytic hydrogen turnover. We furthermore will give an outlook on potential research
activities and exploit the utilization of synthetic cofactor mimics.
Introduction
Hydrogenase enzymes are outstanding natural catalysts for the
heterolytic conversion of protons and electrons into molecular
hydrogen (eqn (1)).1 Depending on the metal composition of
the active site, these enzymes are divided into [NiFe]-, [FeFe]-,
and [Fe]-hydrogenases. They are an important factor for adjusting
the redox balance in green algae, bacteria, and archaea in H2-based
respiration processes.2
2H+ + 2e" [H+ + H]" H2 (1)
Among all hydrogenases, [FeFe]-hydrogenases show an
unsurpassed H2 release activity of up to 8.000 mmol H2min
1 mg1
protein.3 This eﬃciency is based on the unique design of the active
site cofactor (Fig. 1A). An in-depth understanding of the hydro-
genases’ active site structural properties and reactivity is crucial to
develop new catalysts for an eﬃcient H2 production.
4 The potential
for technical applications of such bioinspired approaches was
recently demonstrated at the example of Fe4.5Ni4.5S8.
5–7 This
mineral compound reveals striking similarities with the [NiFe]-
hydrogenase cofactor (Fig. 1B) and binds bridging hydrides in the
electrocatalytic generation of H2.
8 To fully exploit the potential of
biomimetic catalysis, a deeper knowledge about the molecular
proceedings of enzymatic hydrogen turnover is vital including
potential proton pathways, redox and spin states and cofactor
geometry. In the last few years, developments in synthetic, electro-
chemical and spectroscopic methods have led to an improved
understanding of the interplay of electrons and protons at the
active site of [FeFe]-hydrogenases. In particular, site-selective
protonation critically influences the electron density across the
cofactor and conducts redox events in the catalytic cycle. We
herein will focus on the current understanding of proton-coupled
electron transport dynamics of [FeFe]-hydrogenases and recent
developments in modifying the active site cofactor.
The cofactor of the active site
The cofactor of the [FeFe]-hydrogenases is an assembly of two
distinct iron–sulphur sites, in combination referred to as the
‘‘H-cluster’’ (Fig. 1A and 2). Here, a cuboidal [4Fe–4S] cluster is
attached to the protein scaffold by three cysteine residues
([4Fe]H). This [4Fe]H cluster is connected via a fourth cysteine
residue to a unique diiron moiety ([2Fe]H) that represents the
second iron–sulphur site and completes the H-cluster.9,10 The
[4Fe]H and [2Fe]H clusters are about 4 Å apart which facilitates
an efficient electronic coupling. The [2Fe]H cluster is the site of
catalytic turnover and thus requires a more detailed descrip-
tion. It consists of two iron centers in proximal (Fep) or distal
(Fed) position relative to the [4Fe]H cluster. The proximal iron
center is coordinated by one terminal cyanide (pCN
) and a
carbonyl ligand (pCO). Furthermore, it is connected to the
Fig. 1 Schematic representation of the active site cofactor of [FeFe]-
hydrogenases (A) and [NiFe]-hydrogenases (B). The site of catalytic
H2/proton turnover is marked with X.
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[4Fe]H cluster via a cysteine, which is the only covalent anchor
to the protein. A hydrogen bond of pCN
 to the protein scaffold
further stabilizes the [2Fe]H cluster (Fig. 2).
11 The distal iron is
equally coordinated by dCN
 and dCO but additionally features
an open coordination site in apical position. Besides structural
stabilization, the CN ligands are important to adjust the redox
potential of the H-cluster by raising the electron density on the
iron ions.12,13 A third CO ligand bridges both iron centers (mCO)
and forces Fed to adopt the so-called ‘‘rotated state’’.
14 This
geometry stabilizes the open coordination site at Fed which is
responsible for the high activity of the enzyme.
A key feature of all [FeFe]-hydrogenases is the azanediyldi-
methanethiolate group (adt) bridging Fep and Fed.
15–17 This
moiety serves as a proton relay and is positioned at the end of an
amino acid trajectory leading from the [2Fe]H site to the protein
surface. Molecular dynamic (MD) simulations were employed to
characterize this conserved proton transfer path.18–21 It is
formed by two glutamic acid side chains, at least one serine,
one or two water molecules, and a cysteine in close vicinity to the
adt group of the H-cluster (Fig. 2). Moreover, a hydrophobic gas
channel connects the protein surface and the active site niche.22
This channel, however, is unselective for H2 and likewise allows
CO and O2 to approach the [2Fe]H center.
23 While CO reversibly
inhibits the enzymes, O2 irreversibly binds to the [2Fe]H cluster
and eventually leads to degradation of the H-cluster.24,25
Artificial maturation
Although [FeFe]-hydrogenases are a thoroughly investigated
enzyme family, there are eminent gaps in the understanding
of certain redox species and their participation in the catalytic
cycle. Such information is crucial to allow for a rational design of
synthetic, non-noble metal catalysts. While gram-scale synthesis
of potential catalysts is necessary to perform spectroscopic and
kinetic investigations, isolation of large amounts of enzymes
from their natural environment is cumbersome. Furthermore, a
selective manipulation of the important inorganic cofactor is
precluded in vivo and limits the possibilities to investigate
reactions at specific parts of the H-cluster.
In nature, the [FeFe]-hydrogenases are activated by a specific
maturation machinery consisting of HydEFG as well as the
apoprotein, HydA.26,27 Isolation of the homologously synthesized
enzymes provides low yields and renders a detailed study of
these enzymes challenging. Contrary to in vivo isolation methods,
Kuchenreuther et al. presented a method to express [FeFe]-
hydrogenases from C. reinhardtii (HydA1) and C. pasteurianum
(CpI) in genetically modified E. coli cells.28 This method established
a significantly improved isolation protocol and facilitated the
generation of up to 30mg of purified and active [FeFe]-hydrogenase
per liter cell culture. Likewise, the hydrogenase apoprotein
(i.e. without the [2Fe]H cofactor) was obtained using the same
method but in the absence of the maturase genes HydEFG.29
The most striking result on [FeFe]-hydrogenase research was
subsequently reported by Fontecave, Lubitz, and Happe in a
joint project. They were able to show that maturase HydF is
capable of binding and transferring an artificially synthesized
cofactor mimic to apo-HydA1 and generates fully functional
[FeFe]-hydrogenase enzymes.16 An evenmore simplified protocol
was reported briefly afterwards. Starting from inactive HydA1
apoprotein, the synthetically produced cofactor readily inserts
into the enzymatic binding pocket and yields an active enzyme,
most notably in the absence of HydF.15,29,30
The huge advantage of this approach is obvious – both
apoprotein and cofactor can be obtained in gram scale. In addition,
since a synthetic diiron site is added to the inactive enzyme and
is not biosynthesized in parallel to the apoprotein, site-specific
modifications of the [2Fe]H and [4Fe]H cluster are possible. Recently,
this approach enabled for a selective enrichment of [2Fe]H with
spectroscopically relevant isotopes such as 57Fe allowing e.g.
for Mo¨ssbauer- and nuclear vibrational resonance spectroscopic
(NRVS) studies.25,31,32 Following such isotopic labelling studies, the
investigation of specific redox states became feasible (see below).
Furthermore, non-natural variations of the [2Fe]H site such as an
exchange of the bridgehead nitrogen atom (e.g. to CH2, S, or O)
30,33
or replacement of the CO and/or CN ligands by typical inorganic
coordination ligands (e.g. phosphines) became feasible as well.34
While specific isotope editing is used to investigate [FeFe]-
hydrogenases without interfering with the catalytic proper-
ties,25,31,32,35 varying the elemental composition of the H-cluster
can now be applied to alter the H2 evolution performance and
identify structural features fundamental for catalysis.
The incorporation of artificial cofactors can help to under-
stand the enzymatic H2 turnover and opens the possibility to
design eﬀective and durable catalysts. Here, almost all reported
modifications of the H-cluster are located at the [2Fe]H moiety
(Fig. 3) whereas the [4Fe]H cluster has not been addressed to the
same extent. Chalcogenide exchange experiments have been
reported for the [4Fe–4S] cluster of ferredoxin before36–38 and
the strong resemblance with the [4Fe]H cluster has drawn our
attention towards a comparable exchange of the sulphides to
Fig. 2 Crystal structure of the [FeFe]-hydrogenase from C. pasteurianum
(CpI, pdb coordinates 4XDC). The catalytic cofactor comprises a [4Fe]H
cluster and a [2Fe]H cluster (‘‘H-cluster’’). The asterisk denotes a vacant
binding site at the distal iron ion (Fed) of the H-cluster. Key residues are
numbered with respect to HydA1, the [FeFe]-hydrogenase of C. reinhardtii.
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selenides.39 The [4Fe]H cluster can be easily incorporated into the
protein via self-assembly from inorganic iron salts and selenides.
Successful incorporation was confirmed by X-ray crystallography
and anomalous scattering at the 12.666 keV edge of selenium. Such
[4Fe–4Se] apoprotein was activated with the natural [2Fe]H cluster
and yielded wildtype-like H2 release activity. This behavior suggests
a high tolerance of the cofactor towards electronic manipulations.
Alterations of the diiron site have stimulated tremendous
attention.30 While over 300 synthetic mimics are reported in the
literature,42 only a few were yet incorporated into the hydrogenase
enzyme. Utilization of such mimics usually led to inactive enzymes
since the amine of the adt group serves as intrinsic base and proton
relay and is considered a crucial feature of the [2Fe]H cluster (Fig. 3).




2 revealed recognizable H2 release activity.
30
These results indicate that both CN ligands and the ‘‘right’’
basicity of the proton relay site are of utmost importance for
hydrogen turnover. Therefore, it seems obvious that in order to
retain enzyme-like activity a potential mimic should contain
two CN ligands and the adt dithiolate. We subsequently took
the next step and replaced the bridging thiolates of the [2Fe]H
cluster by selenides.43 In line with reports on chalcogenide
replacements within synthetic mimics, we expected that this
S/Se exchange will lead to enhanced catalytic activity, e.g. due to
an increase of electron density at the diiron site and optimized
electron transfer, accordingly.41,44–46 Maturation with the synthetic
adSe cluster was performed47 and yielded the selenium-modified
HydA1 and CpI variants. The modified hydrogenases revealed a
slightly increased H2 release activity as compared to the wildtype
enzyme. Notably, catalytic activity was biased towards proton
reduction. This imbalance between H2 release and uptake is most
likely due to the increased electron density at the diiron site as is
also shown by a bathochromic ‘‘red shift’’ in the IR signature of the
H-cluster compared to native [2Fe]H.
The redox states
Although numerous enzymatic intermediates were observed and
spectroscopically characterized, the details of [FeFe]-hydrogenase
turnover are not fully understood. Only recently with the improved
maturation protocols suﬃcient amounts of protein became
available to perform in-depth enzyme studies on the various
reported intermediates. Among these intermediates, there is
only little debate concerning the oxidized species of the enzyme.
Hox and Hox–CO as well as their protonated counterparts HoxH
and HoxH–CO
48 are all characterized by a [2Fe]H
3+ site with both
iron ions adopting a low-spin state and an oxidized [4Fe–4S]2+
cluster.49 The presumed charge asymmetry in Hox (Fep
I–Fed
II) is
less pronounced in Hox–CO.
49 Since the electron distribution in
the [2Fe]H cluster is still a matter of debate, we will only present
the formal overall charge of the diiron site. There is consensus
that Hox is the resting state of the enzyme and exhibits an open
coordination site for substrate binding to Fed (* in Fig. 2). As a
result of combining real-time attenuated total reflection Fourier-
transform infrared spectroscopy (ATR-FTIR) and density func-
tional theory (DFT), we could recently assign the individual
vibrational modes of Hox and Hox–CO using a specific isotopic
editing protocol.35 Exposure to 13CO gas in combination with
blue or red light irradiation facilitated the generation of eight
possible Hox and 16 Hox–CO isotopomers.
In general, Hox shows three strong stretching frequencies,
assigned to the Fe–Fe bridging carbonyl (mCO, 1802 cm1), the
terminal CO ligand at Fed (dCO, 1940 cm
1) as well as that at
Fep (pCO, 1964 cm
1).52 These modes are largely uncoupled and
agree well with theoretical models that feature all-equatorial
CO and CN ligands at Fed and Fep as depicted in Fig. 4A.
35
Interestingly, distortions of the octahedral geometry at Fed as
shown in Fig. 4B are well compatible with the experimental
frequencies and suggest significant rotational freedom at the
site of catalysis. Upon CO gas exposure, a fourth band at higher
IR frequencies appears that is indicative of an additional CO
ligand at Fed. This is a unique feature of the catalytically
inhibited Hox–CO state.
52 While it was previously believed that
the additional CO molecule blocks the vacant binding site of
Hox (‘‘standard’’ geometry as in Fig. 4C),
53 recent IR spectroscopic
Fig. 3 Possible alterations of the H-cluster, the active site of [FeFe]-
hydrogenases.14,34,40,41
Fig. 4 H-Cluster rotamers of Hox and Hox–CO and their probability
distribution. Both Hox rotamers A and B are equally probable while upon
CO inhibition, the apical CN rotamer (D) is clearly favoured over the
‘‘standard’’ geometry (C). The arrows suggest a possible trajectory for CO
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investigations and DFT calculations suggest that herein a
rotamer with an apical CN is more likely (Fig. 4D).35 The lack
of evidence for an electrostatic interaction between Fed–CN

and the protein, however, still allows for speculations on Fed
rotamers54 and even more substantial differences in cofactor
geometry of other intermediates.55–57
Upon acidification of the enzyme samples, the IR spectrum
of Hox reveals the formation of a new species with an up-shift of
4–6 cm1 for all terminal ligands and up to 10 cm1 higher
values for mCO.48 The formation of this species depends on the
pH value and is fully reversible upon increasing the pH to
alkaline conditions. This hypsochromic ‘‘blue shift’’ does not
occur in the absence of a reductant although the increase of
frequencies suggests a lower electron density at [2Fe]H. Both
one-electron reduction and oxidation of the diiron site lead to
significantly higher IR shifts.58 The small shift observed for all
CO/CN bands upon acidification thus has to correspond to a
novel, protonated redox state and was accordingly labelled
HoxH.
48 Likewise, bacterial [FeFe]-hydrogenases showed this
behavior suggesting the protonated HoxH species to be an
omnipresent intermediate in [FeFe]-hydrogenases. In addition,
the IR shift is not affected by changes in the protein surrounding
the cofactor as shown for amino acid variants containing modifica-
tions at cysteine 169 (Fig. 2) as well as chemical cofactor variations
(e.g. HydA1pdt). Likewise, the blue shift cannot be assigned to a
protonation of Fed since Hox–CO revealed a similar up-shift of
cofactor bands. Acidification under a CO atmosphere subsequently
leads to a new intermediate that was named HoxH–CO. Even upon
S/Se chalcogenide exchange at the [4Fe]H cluster,
39 a comparable
shift of the CO bands was observed that eliminates the sulphides of
the cuboidal cluster as a potential protonation site.59–61 In the
C169A variant, proton transfer towards the adt-ligand is blocked.
Therefore, the protonation reaction must be independent of this
pathway. The X-ray structure of apo-HydA129 reveals that the [4Fe]H
cluster is in direct contact with bulk water while in prokaryotic
hydrogenases it is deeply buried within the protein. Here, a chain
of water molecules extends from the protein surface to cysteine 417
that binds the [4Fe]H cluster (Fig. 5).
62 It was therefore assumed
that this cysteine might act as a possible protonation site. This
hypothesis was supported by DFT calculations and Cys417 was
suggested to be themost-likely candidate for the formation of HoxH
and HoxH–CO.
This [4Fe]H protonation modulates the redox potential of the
H-cluster.55 After receiving a first electron, the enzyme is
typically less likely to accept a second electron. Protonation of
the [4Fe]H cluster may therefore compensate for the negative
charge of the electron and thus the second electron can be
transferred at a comparable potential. While the oxidized states
generally find broad acceptance within the community, the
one-electron reduced states Hred, Hred0, and Hred0H as well as
the inhibited state Hred0–CO and Hsred have been discussed
controversially in recent years.48,50,51,55,63 This mainly stems
from the fact that only a limited amount of spectroscopic data
was available to gain an in-depth structural understanding of
the reduced intermediates. Basically all reduced intermediates
were suggested before 2013, the magic year when the protocols
for artificial maturation were published.15,16 The combination
of increased sample availability and the possibility to change
the cofactor composition led to the observation of additional
redox states. This new input raised questions about previous
assumptions on the role of the different reduced states.
To allow the reader to follow the upcoming discussion, we
like to refer to the nomenclature assigned in Table 1. Starting
from the resting state Hox, reduction of the [2Fe]H site results in
a species, formerly assigned as Hred.
50,63 This state is character-
ized by CO bands at 1962 cm1, 1915 cm1 and 1891 cm1.
Since Mo¨ssbauer studies revealed an oxidized [4Fe]H
2+ cluster
for Hred,
64,65 the [2Fe]H site was therefore assigned to [2Fe]H
2+,
well in line with the largely bathochromically shifted CO bands
in comparison to Hox. The reduced diiron site is paramagnetic
(Table 1). An [4Fe]H
+–[2Fe]H
3+ intermediate could be observed
as well (Hred0, Fig. 6A). To investigate this state in detail, the
semi-artificial enzyme version HydA1pdt was utilized. This
cofactor variant cannot adopt the Hred state due to the absence
of the NH relay site.48 However, the IR spectra of the accessible
states Hox and Hred0 reveal almost identical CO shift patterns as
compared to the wildtype enzyme. At pH 8 and in a pure H2
atmosphere, the IR pattern of Hox fully disappears in favour of
new CO bands at 1962 cm1, 1934 cm1 and 1798 cm1. Under
acidic conditions and otherwise identical experimental settings,
likewise slightly blue-shifted frequencies with respect to Hred0
were observed. This behavior suggests the existence of an
additional intermediate denoted as Hred0H.
48 Recent spectro-
electrochemical measurements show that the formation of
both one-electron reduced species is pH- and potential-
dependent. Furthermore, both intermediates are linked by a
proton-coupled rearrangement.48,51 While the [4Fe]H
2+–[2Fe]H
2+
configuration of Hred dominates at acidic pH, the [4Fe]H
+–
[2Fe]H
3+ intermediate (Hred0) can be enriched at more alkaline
pH values.48 The combination of IR experiments and DFT
frequency calculations allowed for the evaluation of different
Fig. 5 Putative proton path from bulk solvent to the [4Fe]H site of the
H-cluster (pdb coordinates 4XDC). In HydA1, ‘‘Cys-S’’ corresponds to C417.
The water chain is conserved in all crystal structures and can be found in a
cleft between the accessory and catalytic domain. O–O distances are given
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H-cluster geometries. Fig. 6 illustrates that a reduction of the
diiron site from [2Fe]H
3+ to [2Fe]H
2+ induces a down-shift of up
toB50 cm1 for single bands. In comparison, the one-electron
transition Hox - Hred0 or Hred - Hsred results in a red shift
for the CO bands no larger than B10 cm1. Calculations of
Hred0 favored an additional protonation of the [4Fe]H cluster,
just as observed for the Hox- HoxH transition. Again, the best
correlation between measured and calculated IR spectra was
found for an additional protonation at C417 (Fig. 5, Cys-S).
These results clearly showed that the Hred0 intermediate is a
one-electron reduced species comprising a reduced [4Fe]+
cluster and a Hox-like [2Fe]H cluster in terms of valence (I/II)
and geometry (i.e. an open binding site and bridging CO
ligand). The structural relation of Hred0 and Hox is visible by
the distinct IR signals as displayed in Fig. 6A.56 The IR pattern
of Hred, however, clearly indicates a significant structural
change within the [2Fe]H moiety, e.g. the loss of the low-
frequency band assigned to mCO. To elucidate the structure of
Hred, DFT calculations with (i) a hydrogen species at Fed and
with conservative mCO geometry,54 (ii) protonation at N(adt)
with a ‘‘semi-bridging’’ CO at Fed,
51 and (iii) a Fe–Fe bridging
hydride (mH) were performed.57 Best agreement of experimental
and calculated spectra was observed for a [2Fe]H site compris-
ing a bridging hydride. Additionally, only the mH geometry
reproduced the specific down shift of the CN ligand band
characteristic for Hred. Therefore, Hred was assigned to com-
prise a [4Fe]H
2+–[Fe(mH)Fe]2+ cluster.56
Two double-reduced H-cluster intermediates have been
identified, Hhyd and Hsred. The latter is formed upon reduction
of Hred and has been characterized by EPR and FTIR spectro-
scopy as a paramagnetic intermediate of potential catalytic
relevance.66 The low g-values suggest a reduced [4Fe]H
+ cluster
and the CO frequencies at 1953, 1919 and 1882 cm1 closely
resemble the IR signature of Hred (Fig. 6B). This observation
suggests a similar cofactor geometry. As for Hred, best agree-
ment between experimental and calculated frequencies was
obtained for model structures comprising a bridging hydride
in a [4Fe]H
+–[Fe(mH)Fe]2+ assembly.56
An intermediate of more recent prominence is the so-called
hydride state, Hhyd. The name originates from the assumption
that a terminal hydride species necessarily should play a key role
in the heterolytic formation of H2.
67 Hhyd was independently
identified by three groups, which shows the significance of this
particular intermediate. Mulder et al. observed the Hhyd state in the
C169S variant of HydA1.68,69 This modified version of the [FeFe]-
hydrogenase from C. reinhardtii reveals a diminished H2 release
activity due to an impaired proton conductivity and facilitated an
enrichment of the Hhyd state in the presence of H2 (Fig. 7B).
Mo¨ssbauer studies on the C169S variants suggested that Hhyd
consists of a reduced [4Fe]H
+ cluster coupled to a ‘‘superoxidized’’
[2Fe]H
4+ cluster.68 EPR spectroscopy further supported this electro-
nic assignment by an S = 1/2 rhombic 2.07 signal.68 The transition
potential of430mV vs. SHE for the population of Hhyd at pH 8 fits
the catalytic properties of [FeFe]-hydrogenases much better than
Hsred.
66 Additionally, FTIR spectroscopy revealed a small shift of the
bridging CO band upon changing the solvent and atmosphere
from H2O/H2 to D2O/D2. This behavior is consistent with an H/D
exchange of the ligand in trans position to the mCO moiety and
suggests the formation of a terminal hydride (tH) in the amino acid
variant C169S.69
A clean IR spectrum of Hhyd in native HydA1 enzyme was
obtained by accumulation of Hhyd upon concerted increase of
Table 1 Catalytic intermediates of [FeFe]-hydrogenase HYDA1 and vibronic properties
Redox species Hox Hred0 Hred Hsred Hhyd Hox–CO Hred0–CO HoxH Hred0H HoxH–CO
[4Fe–4S]H 2+ 1+ 2+ 1+ 1+ 2+ 1+ 2+ 1+ 2+
Formal charge of
Fep/Fed within [2Fe]H






























































Fig. 6 Experimental IR spectra of HydA1. (A) Species with a 3+ oxidized
diiron site are Hox (black) and Hred0 (red). (B) Species with a 2+ reduced
diiron site are Hred (green) and Hsred (magenta). Note the lack of a mCO
signal and the increased gap between the CN bands in (B). Original data
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substrate and product concentration, i.e. H2 and H
+.33 The
spectra showed a dominant species with bands at 1978, 1960
and 1860 cm1 (Fig. 7C) and correlate well with the observa-
tions by Mulder et al.69 Furthermore, it was demonstrated that
the hydride species exclusively stems from the H2 or D2 sub-
strate and not the solvent. Similar results were obtained using
native DdH and CpI enzymes. At neutral pH, accumulation of
the Hhyd intermediate can be observed upon decreasing the
humidity levels of the protein sample. The lack of bulk water as
the acceptor molecule herein may increase the number of
protons ‘‘stuck’’ inside the protein and was suggested to show
eﬀects comparable to acidification. This also agrees with the
findings of Mulder et al.68 and it seems that a disturbed proton
transport pathway (PTP) is prerequisite for an accumulation of
Hhyd. In an alternative approach as was described by Lubitz and
co-workers,31,70 a variation of the bridgehead atom of [2Fe]H led
to equally suppressed proton conductivity. The semi-artificial
[FeFe]-hydrogenases with an ether bridge (HydA1odt; odt =
oxydimethanethiolate) indeed revealed neither catalytic proton
reduction nor H2 oxidation catalysis. Fig. 7A shows the Hhyd/Hox
diﬀerence spectra for HydA1odt as recorded by real-time ATR-
FTIR spectroscopy.
FTIR spectroscopy is a powerful tool to analyze the active site
cofactor of [FeFe]-hydrogenases and to determine changes in
electron density or evaluate the geometry of otherwise transient
intermediates. However, the artificial maturation pathways
paved the way to apply spectroscopic methods that can give
additional and direct information on the [2Fe]H cluster by
selectively installing specific probes within the H-cluster. For
example, a semi-artificial HydA1 enzyme comprising a Fe57
labelling solely at the [2Fe]H moiety was synthesized and it
allowed for characterizing intermediates via nuclear resonance
vibrational spectroscopy (NRVS).25,31,32 Such NRVS studies on
Fe57 enriched enzyme variants finally enabled the direct observa-
tion of a terminal hydride and confirmed the [4Fe]H
+–[2Fe(tH)]2+
assignment for Hhyd. In addition the first step of the oxidative
degradation (O2 deactivation) was unequivocally shown to proceed
via an iron bound hydroperoxide ligand.25
Fig. 7 Real-time ATR-FTIR accumulation of Hhyd over Hox in presence of
H2. (A) HydA1 cofactor variant odt in black, (B) HydA1 amino acid variant
C169A in red, and (C) wildtype enzyme HydA1adt in blue. Negative bands
are assigned to Hox or HoxH (for wildtype enzyme), positive bands repre-
sent Hhyd. In HydA1
adt traces of Hred are formed (*). Original data taken
from Winkler et al.33
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The catalytic cycle
In the previous chapter, we reviewed recent attempts to identify the
electronic structure of particular H-cluster intermediates. This
made it indispensable to also reconsider the catalytic mechanism
of the H2 formation. An updated catalytic cycle is shown in
Scheme 1. In a first step, Hox is converted to Hred0 by a proton-
coupled electron transfer (PCET) to the [4Fe]H cluster.
55 This PCET
renders the formation of Hred0 charge neutral and may facilitate a
second reduction step at a similar redox potential. The Hox-Hred0
transition appears more likely than a direct conversion into Hred
which would result in drastic ligand reorientation and loss of the
‘‘rotated structure’’.71 While Hred0 is preferably formed at alkaline
pH, Hred accumulated under neutral or slightly acidic conditions.
48
Higher proton concentrations lead to a preferential protonation of
the [2Fe]H site and withdrawal of electron density from the [4Fe]H
cluster resulting in a bridging hydride. Subsequent reduction of
Hred leads to Hsred that carries a bridging hydride as well.
56 The
mH ligand is thermodynamically more stable than a terminal
hydride and bridging hydride species of mimetic model complexes
were shown to react only slowly with additional protons in the H2
release reaction.72 Therefore, the participation of Hred and Hsred as
catalytic intermediates in hydrogen turnover must be questioned.
This statement becomes even more evident when considering that
the formation of Hhyd from Hsred requires another re-organization
of geometry (Scheme 1). It has to be assumed that Hsred and Hred
are a part of a slower H2 formation pathway, e.g. as ‘‘signalling
states’’ in regulatory [FeFe]-hydrogenases.73
Scheme 1 shows an alternative pathway. Here, protonation
and reduction of Hred0 is suggested to lead to the formation of
Hhyd. This state exhibits an apical hydride and does not require
significant structural re-organization. In addition, it was shown
that such hydride intermediates react rapidly with protons to
form H2, facilitating fast turnover within the enzyme.
72 Further
protonation of Hhyd heterolytically yields H2 and recovers the
protonated resting state, HoxH. While HoxH has the same
structure and valence as Hox it still carries an additional proton
at the [4Fe]H cluster.
48 After losing this ‘‘regulatory’’ proton, Hox
is formed again and the catalytic cycle can start over again.
In summary, a fast and eﬃcient H2 release is only feasible
upon conversion of the mCO-geometry and PCET to both the
[4Fe]H cluster and Fed of the [2Fe]H site. The H-cluster is
charged with two electrons to allow for an instant reduction
of a proton into a highly reactive apical hydride. In the end, this
hydride reacts in a simple acid/base reaction with an additional
proton to generate hydrogen.
Conclusion and outlook
Over the past three decades, significant eﬀorts were undertaken
to understand [FeFe]-hydrogenases and mimic their catalytic
activity.1,74,75 It was, however, just recently that a major break-
through in the understanding of the molecular proceedings of
catalysis was achieved. The protocol for artificial maturation
established by Fontecave, Happe and Lubitz allowed for the
production of large amounts of active enzymes and site-
selective modifications of the unique cofactor.15,16 In addition,
synthetic variants of the [2Fe]H and [4Fe]H cluster facilitating
studies of catalytic intermediates were not available to spectro-
scopy before.31,55,68 The example of [FeFe]-hydrogenases shows
how in a truly interdisciplinary way chemists, biologists and
physicists discovered a new path to elucidate the catalytic cycle
of this interesting class of metalloenzymes.
Despite the progress within this research field, numerous
points still need to be addressed. This includes the reaction of
[FeFe]-hydrogenases with molecular oxygen and the subsequent
decomposition of the active site. An O2-oxididized intermediate
was identified just recently,25 supporting earlier attempts to
explain the O2 sensitivity of [FeFe]-hydrogenases by an oxygenase
subroutine that converts O2 as a substrate into reactive oxygen
species (ROS).76 Whether these ROS attack the diiron site, [4Fe]H
cluster, or protein fold remains elusive.24,77 Related to this area,
the minutiae of oxidative inactivation in the absence of O2 are
barely understood. The process is of interest as the DdH enzyme
has been shown to adopt the so-called Hinact state when isolated
in the presence of air.58 The enzyme is on stand-by, does not
show hydrogen turnover in this state (hence the name), and is
completely resistant to O2. Upon reductive activation, Hox is
formed and the [FeFe]-hydrogenase is rendered turnover-active
and O2-sensitive. [FeFe]-Hydrogenases as analysed by protein
film voltammetry (PFV) undergo inactivation at potentials
exceeding +50 mV vs. SHE.23 It is, however, unclear, whether
this observation is related to the formation of Hinact or Htrans
(an intermediate state in the Hinact/Hox redox conversion) and
what ligand might protect the enzyme from O2 damage.
The electron exchange between the active site cofactor,
accessory clusters, and external electron donors is relatively well
understood.78–81 In comparison, proton transfer to the catalytic
cofactor has not been shown experimentally yet. Selective proton
transfer may well be the reason for the outstanding catalytic
performance of [FeFe]-hydrogenases. Potentially involved amino
acids have been identified due to phylogenetic conservation82
and MD simulations.18–21 However, cysteine 169 of the proton
relay group at the cofactor (Fig. 2) is the only residue that has been
verified to propel proton transfer to and from the H-cluster.68,69 The
lack of an immediate trigger to induce a protonation reaction
renders the experimental identification of involved amino acids
challenging.
In addition, time-resolved IR spectroscopy on [FeFe]-
hydrogenases has been demonstrated by Hammarstro¨m and
Dyer.83,84 Here, continuous wave quantum cascade lasers (QCL) are
employed as probing light of high energy density. This allows
measuring single frequencies with nanosecond time resolution.85 It
can be expected that steady-state FTIR spectroscopy and QCL IR
spectroscopy will help in identifying catalytically relevant redox
species. Furthermore, a correlation of changes in the cofactor
regime with diﬀerences in the amide region will include protein
structural changes in the analysis of [FeFe]-hydrogenases.
In the future, the artificial maturation of [FeFe]-hydrogenases
might lead to cofactor variants with severely altered properties
and reaction pathways. As a result of such enzyme manipula-
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Likewise, the altered enzyme might be utilized in the conversion
of formaldehyde to methanol or even in enantioselective hydro-
genation reactions with biologically non-relevant substrates, e.g.
for the synthesis of flurbiprofen which is an important non-
steroidal antiinflammatory drug.86 Likewise, such variations
might lead to more robust enzyme variants that reveal increased
oxygen stability or higher H2 release activity. Such ‘‘improved’’
behavior might, in the very end, enable the application of [FeFe]-
hydrogenases in large scale bio-based H2 generators which is
currently not possible.
The small amount of synthetic biomimetic model complexes
tested in the natural enzyme environment and the even smaller
number of mimics aﬀording active enzymes, however, raise the
question on structural demands for suitable synthetic mimics.
It will be thus of eminent interest to elucidate if any altered
dithiolate moiety is capable of facilitating a wild-type like
proton relay mechanism. Likewise, altered metal contents or
co-ligands might allow us to establish enzymes with altered
chemical properties and are thus, although laborious and
demanding, an interesting target.
In conclusion, the artificial maturation enabled us and other
scientists to obtain new insight into the chemistry of [FeFe]-
hydrogenases within a very short time frame. Functional details
of the catalytic machinery that were previously discussed con-
troversially could now be analysed via hitherto unamenable
spectroscopic methods. With this incorporation, likewise new
information on key steps of the catalytic cycle was obtained and
enzyme variants with biologically non-relevant cofactors were
established.
It is thus feasible to believe that in the near future, the
remaining questions will be resolved and new enzyme variants
with designed properties and reactivities will be accessible.
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